 |
||||||||
 |
|
 |
 |
 |
 |
 |
|
|
|
Kent Gossett - PartnerKent joined SR One in 2003. He is a member of the Board of Directors of CalciMedica, Alios BioPharma, Nimbus Discovery, and Locus (Ansaris) Pharmaceuticals, and an Observer for Scynexis Pharmaceuticals. He was previously Director of Protez Pharmaceuticals (acquired by Novartis), Algeta ASA (IPO on Oslo Exchange), and Alere Medical (acquired by TA Associates) and Observer for Morphotek Inc (acquired by Eisai). Kent has over 20 years of experience in the pharmaceutical industry with a background in safety assessment, drug development, and licensing. Kent received his DVM and MS from Purdue University, his PhD in Veterinary Clinical Pathology from Louisiana State University, is a Diplomat of the American College of Veterinary Pathologists, and received his MBA from the Wharton School of the University of Pennsylvania.
|
|